Every investor in Proto Labs, Inc. (NYSE:PRLB) should be aware of the most powerful shareholder groups. Institutions often own shares in more established companies, while it's not unusual to see ...
The model performs competitively with leading structure-based tools in predicting binding strength, while also generating novel and chemically diverse compounds. SINGAPORE, June 25, 2025 (GLOBE ...
The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. An international ...
ProtoBind-Diff generates drug-like molecules for specific protein targets using only their amino acid sequences—no 3D structures required. The model performs competitively with leading structure-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback